Home Covid-19
The lung disease Covid-19, which is caused by the novel coronavirus known as SARS-CoV-2, has the world in its grip. GBN is bringing biobanks and researchers together to gain insights into the disease and develop treatments.
See here for information on handling biosamples as well as further literature.
From swabs to whole blood – these German biobanks are collecting SARS-CoV-2 samples.
01/29/2024
Sara Nußbeck will take over the management of the German Biobank Node (GBN) together with Gabriele Anton and Michael Kiehntopf from 1 February 2024.
01/23/2024
In this interview, the current head of the German Biobank Node (GBN) looks back on ten years at the helm of the umbrella organisation for biobanks.
01/17/2024
In 2014, the umbrella organisation of academic biobanks was established and has since supported a decade of progress in biomedical research.
germanbiobanknode@charite.de
Tel. +49. 30. 450 536 347
Fax +49. 30. 450 753 69 38
© 2024 All rights reserved.